Drug Trial Radar · NCT05451199
A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis
Last checked: Nov 19, 2026Latest source record: Apr 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
154
Planned (sponsor's estimate)
Start
Jul 29, 2022
Primary completion
Oct 30, 2023
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 11, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Single and Multiple AscendingDose Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ICP-488 in Healthy Subjects and Patients With Psoriasis
Conditions
- Psoriasis
Interventions
ICP-488Drug
ICP-488 will be administered as tablet
PlaceboDrug
Matching placebo will be administered as tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of adverse events during treatment, and withdrawal from treatment due to adverse eventsTime frame: Single ascending dose: 1day;Multiple ascending dose: 28 days
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
The Second Hospital of Anhui Meidcal University
Hefei, Anhui, China · Not yet recruiting
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Not yet recruiting
Nanyang First People's Hospital
Nanyang, Henan, China · Not yet recruiting
Shiyan Renmin Hospital
Shiyan, Hubei, China · Recruiting
Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of medical Sciences, Peking Union Medical College
Nanjing, Jiangsu, China · Recruiting
Yanbian University Hospital
Yanji, Jilin, China · Not yet recruiting
Hangzhou First People's Hospital
Hangzhou, Zheajing, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.